The purpose of this study is to determine if immune responses differ when the mRNA COVID-19 vaccine is given through different delivery methods, including a needle-free injection system, or via intramuscular injection using needle and syringe
Able to understand and give informed consent
Adults aged 18 to 50 years old.
Willing and able to comply with all scheduled visits, vaccination, and laboratory tests.
Determined by investigator to be in good health based on medical history, targeted physical exam and laboratory testing.
Receipt of blood products 90 days prior to study entry and for the duration of the study.
Volunteers who donated blood 60 days before screening OR will donate blood on or before D30.
Receipt of any experimental agents within 30 days or 5 half-lives whichever is longer prior to vaccination and for the duration of the study.
Receipt of any licensed vaccine within 60 days prior to study vaccination or planned receipt of any vaccine until 60 days later as well as receipt of COVID-19 vaccine for the duration of the study.
PharmaJet, Inc.
Lead sponsor
Emory University
Collaborator